KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Free Cash Flow (2016 - 2026)

Staar Surgical (STAA) has disclosed Free Cash Flow for 17 consecutive years, with -$5.6 million as the latest value for Q1 2026.

  • For the quarter ending Q1 2026, Free Cash Flow fell 9.99% year-over-year to -$5.6 million, compared with a TTM value of -$40.0 million through Jan 2026, down 422.23%, and an annual FY2026 reading of -$40.0 million, down 422.23% over the prior year.
  • Free Cash Flow was -$5.6 million for Q1 2026 at Staar Surgical, down from $1.8 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $28.9 million in Q4 2023 and bottomed at -$29.0 million in Q2 2025.
  • Average Free Cash Flow over 5 years is -$2.1 million, with a median of -$5.3 million recorded in 2024.
  • The sharpest move saw Free Cash Flow crashed 255.18% in 2022, then soared 2837.54% in 2023.
  • Year by year, Free Cash Flow stood at -$1.1 million in 2022, then skyrocketed by 2837.54% to $28.9 million in 2023, then tumbled by 117.6% to -$5.1 million in 2024, then soared by 135.1% to $1.8 million in 2025, then plummeted by 413.4% to -$5.6 million in 2026.
  • Business Quant data shows Free Cash Flow for STAA at -$5.6 million in Q1 2026, $1.8 million in Q3 2025, and -$29.0 million in Q2 2025.